SEOVF (Sernova Biotherapeutics) Accounts Payable: $3.66 Mil (As of Apr. 2026)


SEOVF Sernova Biotherapeutics Inc SEOVF
31 GF Score
Price $0.09
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Accounts Payable?

Sernova Biotherapeutics SEOVF -0.98% 31 Accounts Payable is $3.66 Mil as of Apr. 2026. GuruFocus rates SEOVF with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Sernova Biotherapeutics's Accounts Payable for the quarter that ended in Apr. 2026 was $3.66 Mil.

Sernova Biotherapeutics's quarterly Accounts Payable increased from Oct. 2025 ($3.69 Mil) to Jan. 2026 ($3.93 Mil) but then declined from Jan. 2026 ($3.93 Mil) to Apr. 2026 ($3.66 Mil).

Sernova Biotherapeutics's annual Accounts Payable increased from Oct. 2023 ($5.00 Mil) to Oct. 2024 ($12.54 Mil) but then declined from Oct. 2024 ($12.54 Mil) to Oct. 2025 ($3.69 Mil).

Sernova Biotherapeutics Accounts Payable Related Terms

Sernova Biotherapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Accounts Payable Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 2.64 5.00 12.54 3.69

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 3.69 3.93 3.66
SEOVF
31GF Score
Sernova Biotherapeutics Inc SEOVF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $3.66 Mil mean?
Sernova Biotherapeutics (SEOVF) has a Accounts Payable of $3.66 Mil as of Apr. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Accounts Payable too high?
Sernova Biotherapeutics' current Accounts Payable is $3.66 Mil. Overall, Sernova Biotherapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Accounts Payable compare to VRTX and REGN?
Sernova Biotherapeutics' Accounts Payable of $3.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Accounts Payable is $3.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (SEOVF) has a current Accounts Payable of $3.66 Mil. The current Accounts Payable is $3.66 Mil. Sernova Biotherapeutics' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Sernova Biotherapeutics (SEOVF), the current Accounts Payable is $3.66 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges PSH0:GermanySVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
31GF Score

Get the complete analysis for SEOVF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price